How much valerenic acid is enough?

AHPA calls for dialogue with ConsumerLab over testing methods

By Shane Starling

In the midst of a dispute over valerian product testing standards that has escalated into something far more rancorous, the American Herbal Products Association (AHPA) has called on to seek industry counsel over those very same standards.

Duro has been pulled from the market by its maker

Contaminated herbal Viagra withdrawn

By Shane Starling

A herbal erectile dysfunction (ED) dietary supplement has been voluntary withdrawn from the US market by its Floridian manufacturer after it was alerted to a contamination problem with the unauthorized substance, sildenafil.

Coffee extract achieves GRAS status

Coffee extract achieves GRAS status

Illinois-based FutureCeuticals has self-affirmed GRAS status in the US for its line of patented coffee extracts after an assessment by a three-strong independent panel.

Pontakios: Irradiation problems despite GMP crackdown

Dispatches from SupplySide West

Price drives ongoing illegal irradiation practices

By Shane Starling

Irradiation has risen in importance as it has become specifically outlawed in new Good Manufacturing Practice (GMP) regulations. But the practice continues due to its ability to cheaply remove contaminants from raw materials.

USADA's Tygart says dietary supplements are still dogged by quality 'confidence killers'

Dispatches from SupplySide West

USADA chief explains dietary supplement ‘confidence killers’

By Shane Starling caught up with United States Anti-Doping Agency chief executive officer, Travis Tygart, at the recent SupplySide West trade show in Las Vegas to get an update on USADA’s position on dietary supplements.

GMPs are working, but industry must keep working at them

Dispatches from SupplySide West

Three chiefs, GMPs, AERs and industry's ‘pretty choir’

By Shane Starling

In part two of this special interview with the heads of the major US dietary supplement trade groups, the three chiefs unpack the state of play for Good Manufacturing Practices (GMPs) along with adverse event reporting (AERs).

Meridia withdrawal has raised issue issue of sibutramine contamination

Wall Street Journal raises subatramine contamination question

By Shane Starling

Following last Friday’s decision by Abbott Laboratories to pull its sibutramine-containing weight loss drug Meridia due to concerns about side effects, questions are being asked about dietary supplement contamination with the substance.

Follow us


View more